In this interview, Robert Durham gives an overview of the new Gyrolab® xPand from Gyros Protein Technologies, presented at WRIB this year.
The 2018 Bioanalysis Rising Star Award finalists have been announced! Meet Lisa O’Callaghan (Merck, PA, USA) your 2018 BRSA finalist.
The 2018 Bioanalysis Rising Star Award finalists have been announced! Meet Buyun Chen (Genentech, CA, USA) your 2018 BRSA finalist.
In this interview, Song Li from Frontage Laboratories (PA, USA) discusses the key challenges of outsourcing in the bioanalytical field, as well as his thoughts and perspectives on what the future holds for the relationship between CROs and pharma.
In this interview, Nico and Chad (PRA Health Sciences; NC, USA) discuss the advantages, disadvantages and challenges they face with the technologies they utilize, before predicting what the future holds for the field.
In this interview, Jun Qu (University at Buffalo; NY, USA) describes his current research focuses, including the technologies he is currently developing. Jun goes on to discuss the challenges involved in implementing sensitive quantifications of biotherapeutics using LC–MS and speculates on the future of the technology.
Rob Wheller, Principal Scientist from LGC (Fordham, UK), discusses his current research focuses; the advantages, disadvantages and challenges of the technologies he utilizes; and advice he would give to young, early-career scientists.
In this interview, John Kellie (GSK, PA, USA) discusses the technologies that he uses on a regular basis. He explains how large molecule bioanalysis influences downstream drug development and his future outlook on where the field will be in 5–10 years’ time.
In this interview, Lawrence Goodwin (KCAS, KS, USA) explains his passion for tandem technology, the portfolio of services that KCAS offers and the advantages and disadvantages of their key technologies chromatography and mass spectrometry.